Literature DB >> 3029957

Uncoating of parental bluetongue virus to core and subcore particles in infected L cells.

H Huismans, A A van Dijk, H J Els.   

Abstract

A study was made of the fate of parental bluetongue virus (BTV) in infected cells. Within the first hour after infection, the BTV particles are converted to core particles with the loss of major capsid polypeptides P2 and P5. The particles are able to synthesize mRNA in vitro in a transcription reaction characterized by a temperature-dependent inhibition at high core concentrations. From about 6 hr after infection a second uncoating event is observed in which the 470 S core particles are converted to 390 S subcore particles. These particles are morphologically strikingly different from core particles and have a skeletonlike structure with a hexagonal profile and a side to side diameter of 40 nm. These subcore particles contain only one major structural protein, P3, and three minor proteins, P1, P4, and P6. They do, however, contain all 10 double-stranded RNA segments. The results suggest that the characteristic capsomeres on the surface of core particles are composed mainly of P7, the soluble group-specific antigen of BTV. The subcore particles are stable only at very low salt concentrations. Under these conditions no transcriptase activity can be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029957     DOI: 10.1016/0042-6822(87)90327-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Three-dimensional structure of single-shelled bluetongue virus.

Authors:  B V Prasad; S Yamaguchi; P Roy
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Cryo-EM structure of a transcribing cypovirus.

Authors:  Chongwen Yang; Gang Ji; Hongrong Liu; Kai Zhang; Guangqiao Liu; Fei Sun; Ping Zhu; Lingpeng Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-06       Impact factor: 11.205

3.  Protein P4 of double-stranded RNA bacteriophage phi 6 is accessible on the nucleocapsid surface: epitope mapping and orientation of the protein.

Authors:  P M Ojala; J T Juuti; D H Bamford
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  In vitro reconstitution of Bluetongue virus infectious cores.

Authors:  Sofia Lourenco; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

5.  RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.

Authors:  B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; P Roy
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization.

Authors:  S H Hassan; C Wirblich; M Forzan; P Roy
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV.

Authors:  T J French; P Roy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Identification of bluetongue virus VP6 protein as a nucleic acid-binding protein and the localization of VP6 in virus-infected vertebrate cells.

Authors:  P Roy; A Adachi; T Urakawa; T F Booth; C P Thomas
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

9.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.